TOKYO -- Japanese pharmaceutical companies including Daiichi Sankyo and Fujifilm Holdings are increasing efforts to develop biopharmaceutical talent, aiming for 50% to 100% growth in such experts as they seek to catch up with overseas rivals.
These companies want individuals holding science degrees in related fields with knowledge in biotechnology or life sciences, particularly areas such as cells, genes, microbes and the immune system. They are expected to handle the development and manufacturing of biopharmaceuticals.
